Nxera Pharma
Tracked across 2 events · 18 articles · First seen Feb 12, 2026 · Last active Apr 20, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
NewsDesk Dashboard
Business
Nxera Pharma received a US$3 million milestone payment from Centessa Pharmaceuticals, which will be recognized as revenue in the first quarter of 2026. This payment is a positive financial development for Nxera Pharma.
Feb 12, 2026 · 9 articles
Business
Nxera Pharma received a US$10 million milestone payment from AbbVie Inc. for achieving a third R&D milestone in their collaboration. This payment contributes to Nxera Pharma's financial stability and validates its NxWave platform, potentially increasing investor confidence.
Apr 20, 2026 · 9 articles
95
Nxera Pharma received milestone payment AbbVieNxera Pharma receives...
95
AbbVie made milestone payment Nxera PharmaNxera Pharma receives...
90
Nxera Pharma achieved R&D milestoneNxera Pharma receives...
Centessa Pharmaceuticals
research collaboration partner
↔
Nxera Pharma
Nxera Pharma and Centessa Pharmaceuticals have a research collaboration agreemen
Christopher Cargill
CEO
↔
Nxera Pharma
Christopher Cargill is the President and CEO of Nxera Pharma.
NEWSDESK
Track Nxera Pharma live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard